Document is current
Any future updates will be listed below
-
Authors
Hamoda, Mohamed
El-Maksoud, Amina Abd
Yousef, Aida M.
Fahmy, Dalia Monir
Tohlob, Mohamed
- License Information
-
More Information
Article History
Received: 13 June 2024
Accepted: 30 August 2024
First Online: 4 September 2024
Declarations
:
: Study protocol was approved by Institutional Research Board, Faculty of Medicine, Mansoura University, with the proposal code: MD.21.09.526.R1. This study was registered at ClinicalTrials.gov with title “Anti-inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis” with ID NCT05648734. Written consents were obtained from all patients.
: Not applicable.
: The authors declare no conflict of interest.
